Alalwan Adel A, Taher Abdulraqeeb, Alaradi Ali H
Nephrology, Salmaniya Medical Complex, Manama, BHR.
Cureus. 2020 May 6;12(5):e7995. doi: 10.7759/cureus.7995.
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus that has spread rapidly, resulting in a worldwide pandemic. Even though end-stage renal disease (ESRD) patients are particularly susceptible to COVID-19 infection and can develop severe to critical disease, there are limited studies and case reports about COVID-19 in ESRD patients. We report a case of a 63-year-old gentleman with ESRD on regular hemodialysis. We describe the clinical presentation of this patient, the diagnostic process, the laboratory and imaging investigations, as well as the course of treatment. He positively responded to a 14-day course of Lopinavir-Ritonavir, Ribavirin, Azithromycin, and Hydroxychloroquine.
2019冠状病毒病（COVID-19）是一种由新型冠状病毒引起的传染病，该病毒传播迅速，已导致全球大流行。尽管终末期肾病（ESRD）患者特别容易感染COVID-19，且可能发展为重症甚至危重症，但关于ESRD患者感染COVID-19的研究和病例报告有限。我们报告一例63岁定期接受血液透析的ESRD男性患者。我们描述了该患者的临床表现、诊断过程、实验室和影像学检查以及治疗过程。他对洛匹那韦-利托那韦、利巴韦林、阿奇霉素和羟氯喹的14天疗程治疗反应良好。
